261 related articles for article (PubMed ID: 27538572)
1. A Pseudomonas aeruginosa hepta-acylated lipid A variant associated with cystic fibrosis selectively activates human neutrophils.
SenGupta S; Hittle LE; Ernst RK; Uriarte SM; Mitchell TC
J Leukoc Biol; 2016 Nov; 100(5):1047-1059. PubMed ID: 27538572
[TBL] [Abstract][Full Text] [Related]
2. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
3. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
4. Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.
Hill PJ; Scordo JM; Arcos J; Kirkby SE; Wewers MD; Wozniak DJ; Torrelles JB
Sci Rep; 2017 Jul; 7(1):4761. PubMed ID: 28684799
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4.
Ernst RK; Hajjar AM; Tsai JH; Moskowitz SM; Wilson CB; Miller SI
J Endotoxin Res; 2003; 9(6):395-400. PubMed ID: 14733728
[TBL] [Abstract][Full Text] [Related]
6. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
Ernst RK; Yi EC; Guo L; Lim KB; Burns JL; Hackett M; Miller SI
Science; 1999 Nov; 286(5444):1561-5. PubMed ID: 10567263
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
[TBL] [Abstract][Full Text] [Related]
8. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
10. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
Greene CM; Carroll TP; Smith SG; Taggart CC; Devaney J; Griffin S; O'neill SJ; McElvaney NG
J Immunol; 2005 Feb; 174(3):1638-46. PubMed ID: 15661927
[TBL] [Abstract][Full Text] [Related]
11. Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.
Di Lorenzo F; Silipo A; Bianconi I; Lore' NI; Scamporrino A; Sturiale L; Garozzo D; Lanzetta R; Parrilli M; Bragonzi A; Molinaro A
Mol Immunol; 2015 Feb; 63(2):166-75. PubMed ID: 24856407
[TBL] [Abstract][Full Text] [Related]
12. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.
Pestrak MJ; Chaney SB; Eggleston HC; Dellos-Nolan S; Dixit S; Mathew-Steiner SS; Roy S; Parsek MR; Sen CK; Wozniak DJ
PLoS Pathog; 2018 Feb; 14(2):e1006842. PubMed ID: 29394295
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.
Martin C; Ohayon D; Alkan M; Mocek J; Pederzoli-Ribeil M; Candalh C; Thevenot G; Millet A; Tamassia N; Cassatella MA; Thieblemont N; Burgel PR; Witko-Sarsat V
Am J Respir Cell Mol Biol; 2016 May; 54(5):740-50. PubMed ID: 26517580
[TBL] [Abstract][Full Text] [Related]
15. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
[TBL] [Abstract][Full Text] [Related]
17. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.
Hughes JE; Stewart J; Barclay GR; Govan JR
Infect Immun; 1997 Oct; 65(10):4281-7. PubMed ID: 9317038
[TBL] [Abstract][Full Text] [Related]
18. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.
Parker D; Cohen TS; Alhede M; Harfenist BS; Martin FJ; Prince A
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):6-13. PubMed ID: 21778412
[TBL] [Abstract][Full Text] [Related]
19. The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection.
Moskowitz SM; Ernst RK
Subcell Biochem; 2010; 53():241-53. PubMed ID: 20593270
[TBL] [Abstract][Full Text] [Related]
20. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.
Yoo DG; Winn M; Pang L; Moskowitz SM; Malech HL; Leto TL; Rada B
J Immunol; 2014 May; 192(10):4728-38. PubMed ID: 24740504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
